Evolving Understanding of the Causes of Pneumonia in Adults, with Special Attention to the Role of Pneumococcus

Clinical Infectious Diseases

Volumn 65, Issue 10, 2017, Pages 1736-1744

  Musher, Daniel M ^a,b   Abers, Michael S ^c,d   Bartlett, John G ^e  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b MICHAEL E DEBAKEY VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

^e JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

antibiotic stewardship; community acquired pneumonia; etiology; pneumococcus; Streptococcus pneumoniae

Indexed keywords

ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT;

ADULT; ANAEROBIC BACTERIUM; CHLAMYDIA; COMMUNITY ACQUIRED PNEUMONIA; HAEMOPHILUS INFLUENZAE; HUMAN; LEGIONELLA; MIXED INFECTION; MYCOPLASMA; NONHUMAN; PNEUMOCOCCAL INFECTION; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; REVIEW; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE; VIRUS; ANTIMICROBIAL STEWARDSHIP; COMMUNITY ACQUIRED INFECTION; MICROBIOLOGY; PNEUMONIA; STREPTOCOCCUS PNEUMONIA; VIROLOGY;

ANTI-BACTERIAL AGENTS; ANTIMICROBIAL STEWARDSHIP; COMMUNITY-ACQUIRED INFECTIONS; HUMANS; PNEUMONIA; PNEUMONIA, PNEUMOCOCCAL; STREPTOCOCCUS PNEUMONIAE;

EID: 85032727758     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/cix549     Document Type: Review

References (140)

1. Osler W. The Principles and Practice of Medicine: Designed for the Use of Practitioners and Students of Medicine. First ed. Edinburgh & London: Young J. Pentland, 1892.
2. Osler W. The Principles and Practice of Medicine: Designed for the Use of Practitioners and Students of Medicine. 8th ed. New York and London: D. Appleton and Company, 1914.
3. Griffin MR, Zhu Y, Moore MR, Whitney CG, Grijalva CG. U. S. hospitalizations for pneumonia after a decade of pneumococcal vaccination. N Engl J Med 2013; 369:155-63.
4. Avery OT, Chickering HT, Cole R, Dochez AR. Acute lobar pneumonia: prevention and serum treatment. Monographs of the Rockefeller Institute for Medical Research. New York: Rockefeller Institute for Medical Research, 1917.
5. Cecil RL, Larsen NP. Clinical and bacteriologic study of one thousand cases of lobar pneumonia. JAMA 1922; 79:343-9.
6. Sutliff WD, Finland M. The significance of the newly classified types of pneumococci in disease: types IV to XX inclusive. JAMA 1933; 101:1289-95.
7. Bullowa JGM. The Management of the Pneumonias: For Physicians and Medical Students. New York: Oxford University Press, 1937.
8. Cecil RL, Lawrence EA. Pneumonia in private practice: a study of 911 patients. JAMA 1938; 111:1889-94.
9. Warner GF, Li JG, Farber SM. A study of pneumonia in San Francisco, 1943-1944. Cal West Med 1945; 62:161-2.
10. Warner GF, Gardner FH. A further study of pneumonia in San Francisco, 1944-1946. Calif Med 1948; 68:32-4.
11. Dowling HF, Sweet LK, Hirsh HL. The Acute Bacterial Diseases. Philadelphia: W. B. Saunders Co., 1948.
12. Tillotson JR, Finland M. Bacterial colonization and clinical superinfection of the respiratory tract complicating antibiotic treatment of pneumonia. J Infect Dis 1969; 119:597-624.
13. Fiala M. A study of the combined role of viruses, mycoplasmas and bacteria in adult pneumonia. Am J Med Sci 1969; 257:44-51.
14. Fekety FR Jr, Caldwell J, Gump D, et al. Bacteria, viruses, and mycoplasmas in acute pneumonia in adults. Am Rev Respir Dis 1971; 104:499-507.
15. Dorff GJ, Rytel MW, Farmer SG, Scanlon G. Etiologies and characteristic features of pneumonias in a municipal hospital. Am J Med Sci 1973; 266:349-58.
16. Moore MA, Merson MH, Charache P, Shepard RH. The characteristics and mortality of outpatient-acquired pneumonia. Johns Hopkins Med J 1977; 140:9-14.
17. Oseasohn R, Skipper BE, Tempest B. Pneumonia in a Navajo community: a twoyear experience. Am Rev Respir Dis 1978; 117:1003-9.
18. Miller J, Sande MA, Gwaltney JM Jr, Hendley JO. Diagnosis of pneumococcal pneumonia by antigen detection in sputum. J Clin Microbiol 1978; 7:459-62.
19. Ebright JR, Rytel MW. Bacterial pneumonia in the elderly. J Am Geriatr Soc 1980; 28:220-3.
20. Boerner DF, Zwadyk P. The value of the sputum gram's stain in community-acquired pneumonia. JAMA 1982; 247:642-5.
21. Dans PE, Charache P, Fahey M, Otter SE. Management of pneumonia in the prospective payment era. A need for more clinician and support service interaction. Arch Intern Med 1984; 144:1392-7.
22. Marrie TJ, Haldane EV, Faulkner RS, Durant H, Kwan C. Community-acquired pneumonia requiring hospitalization. Is it different in the elderly? J Am Geriatr Soc 1985; 33:671-80.
23. Larsen RA, Jacobson JA. Diagnosis of community-acquired pneumonia: experience at a community hospital. Compr Ther 1984; 10:20-5.
24. Fang GD, Fine M, Orloff J, et al. New and emerging etiologies for community-acquired pneumonia with implications for therapy. A prospective multicenter study of 359 cases. Medicine (Baltimore) 1990; 69:307-16.
25. Farr BM, Sloman AJ, Fisch MJ. Predicting death in patients hospitalized for community-acquired pneumonia. Ann Intern Med 1991; 115:428-36.
26. Bates JH, Campbell GD, Barron AL, et al. Microbial etiology of acute pneumonia in hospitalized patients. Chest 1992; 101:1005-12.
27. Mundy LM, Auwaerter PG, Oldach D, et al. Community-acquired pneumonia: impact of immune status. Am J Respir Crit Care Med 1995; 152:1309-15.
28. Marston BJ, Plouffe JF, File TM Jr, et al. Incidence of community-acquired pneumonia requiring hospitalization. Results of a population-based active surveillance study in Ohio. The Community-based Pneumonia Incidence Study Group. Arch Intern Med 1997; 157:1709-18.
29. Fine MJ, Stone RA, Singer DE, et al. Processes and outcomes of care for patients with community-acquired pneumonia: results from the Pneumonia Patient Outcomes Research Team (PORT) cohort study. Arch Intern Med 1999; 159:970-80.
30. Park DR, Sherbin VL, Goodman MS, et al; Harborview CAP Study Group. The etiology of community-acquired pneumonia at an urban public hospital: influence of human immunodeficiency virus infection and initial severity of illness. J Infect Dis 2001; 184:268-77.
31. Yang S, Lin S, Khalil A, et al. Quantitative PCR assay using sputum samples for rapid diagnosis of pneumococcal pneumonia in adult emergency department patients. J Clin Microbiol 2005; 43:3221-6.
32. Restrepo MI, Mortensen EM, Velez JA, Frei C, Anzueto A. A comparative study of community-acquired pneumonia patients admitted to the ward and the ICU. Chest 2008; 133:610-7.
33. Musher DM, Roig IL, Cazares G, Stager CE, Logan N, Safar H. Can an etiologic agent be identified in adults who are hospitalized for community-acquired pneumonia: results of a one-year study. J Infect 2013; 67:11-8.
34. Jain S, Self WH, Wunderink RG, et al; CDC EPIC Study Team. Communityacquired pneumonia requiring hospitalization among U. S. adults. N Engl J Med 2015; 373:415-27.
35. Hug B, Rossi M. A year's review of bacterial pneumonia at the central hospital of Lucerne, Switzerland. Swiss Med Wkly 2001; 131:687-92.
36. Garbino J, Sommer R, Gerber A, et al. Prospective epidemiologic survey of patients with community-acquired pneumonia requiring hospitalization in Switzerland. Int J Infect Dis 2002; 6:288-93.
37. Genne D, Siegrist HH, Lienhard R. Enhancing the etiologic diagnosis of community-acquired pneumonia in adults using the urinary antigen assay (Binax NOW). Int J Infect Dis 2006; 10:124-8.
38. Piso RJ, Iven-Koller D, Koller MT, Bassetti S. The routine use of urinary pneumococcal antigen test in hospitalised patients with community acquired pneumonia has limited impact for adjustment of antibiotic treatment. Swiss Med Wkly 2012; 142:w13679.
39. Stralin K, Olcen P, Tornqvist E, Holmberg H. Definite, probable, and possible bacterial aetiologies of community-acquired pneumonia at different CRB-65 scores. Scand J Infect Dis 2010; 42:426-34.
40. Johansson N, Kalin M, Tiveljung-Lindell A, Giske CG, Hedlund J. Etiology of community-acquired pneumonia: increased microbiological yield with new diagnostic methods. Clin Infect Dis 2010; 50:202-9.
41. Pareja A, Bernal C, Leyva A, Piedrola G, Maroto MC. Etiologic study of patients with community-acquired pneumonia. Chest 1992; 101:1207-10.
42. Almirall J, Morato I, Riera F, et al. Incidence of community-acquired pneumonia and Chlamydia pneumoniae infection: a prospective multicentre study. Eur Respir J 1993; 6:14-8.
43. Lorente ML, Falguera M, Nogues A, Gonzalez AR, Merino MT, Caballero MR. Diagnosis of pneumococcal pneumonia by polymerase chain reaction (PCR) in whole blood: a prospective clinical study. Thorax 2000; 55:133-7.
44. Almirall J, Bolibar I, Vidal J, et al. Epidemiology of community-acquired pneumonia in adults: a population-based study. Eur Respir J 2000; 15:757-63.
45. Gutierrez F, Masia M, Rodriguez JC, et al. Epidemiology of community-acquired pneumonia in adult patients at the dawn of the 21st century: a prospective study on the Mediterranean coast of Spain. Clin Microbiol Infect 2005; 11:788-800.
46. Andreo F, Dominguez J, Ruiz J, et al. Impact of rapid urine antigen tests to determine the etiology of community-acquired pneumonia in adults. Respir Med 2006; 100:884-91.
47. Briones ML, Blanquer J, Ferrando D, Blasco ML, Gimeno C, Marin J. Assessment of analysis of urinary pneumococcal antigen by immunochromatography for etiologic diagnosis of community-acquired pneumonia in adults. Clin Vaccine Immunol 2006; 13:1092-7.
48. Fernandez Alvarez R, Suarez Toste I, Rubinos Cuadrado G, et al. Communityacquired pneumonia: aetiologic changes in a limited geographic area. An 11-year prospective study. Eur J Clin Microbiol Infect Dis 2007; 26:495-9.
49. Falguera M, Carratala J, Ruiz-Gonzalez A, et al. Risk factors and outcome of community-acquired pneumonia due to gram-negative bacilli. Respirology 2009; 14:105-11.
50. Cilloniz C, Ewig S, Polverino E, et al. Microbial aetiology of community-acquired pneumonia and its relation to severity. Thorax 2011; 66:340-6.
51. Sorde R, Falco V, Lowak M, et al. Current and potential usefulness of pneumococcal urinary antigen detection in hospitalized patients with community-acquired pneumonia to guide antimicrobial therapy. Arch Intern Med 2011; 171:166-72.
52. Capelastegui A, Espana PP, Bilbao A, et al; Poblational Study of Pneumonia (PSoP) Group. Etiology of community-acquired pneumonia in a population-based study: link between etiology and patients characteristics, process-of-care, clinical evolution and outcomes. BMC Infect Dis 2012; 12:134.
53. Viasus D, Marinescu C, Villoslada A, et al; Influenza A (H1N1) Study Group of the Spanish Network for Research in Infectious Diseases (REIPI). Communityacquired pneumonia during the first post-pandemic influenza season: a prospective, multicentre cohort study. J Infect 2013; 67:185-93.
54. Tudose C, Moisoiu A, Bogdan M. Mortality risk and etiologic spectrum of community-acquired pneumonia in hospitalized adult patients. Maedica (Buchar) 2010; 5:258-64.
55. Roysted W, Simonsen O, Jenkins A, et al. Aetiology and risk factors of community-acquired pneumonia in hospitalized patients in Norway. Clin Respir J 2016; 10:756-64.
56. Boersma WG, Lowenberg A, Holloway Y, Kuttschrutter H, Snijder JA, Koeter GH. Pneumococcal capsular antigen detection and pneumococcal serology in patients with community acquired pneumonia. Thorax 1991; 46:902-6.
57. Bohte R, van Furth R, van den Broek PJ. Aetiology of community-acquired pneumonia: a prospective study among adults requiring admission to hospital. Thorax 1995; 50:543-7.
58. Endeman H, Schelfhout V, Voorn GP, van Velzen-Blad H, Grutters JC, Biesma DH. Clinical features predicting failure of pathogen identification in patients with community acquired pneumonia. Scand J Infect Dis 2008; 40:715-20.
59. Huijts SM, Boersma WG, Grobbee DE, et al; CAP Diagnostics Investigators. Predicting pneumococcal community-acquired pneumonia in the emergency department: evaluation of clinical parameters. Clin Microbiol Infect 2014; 20:1316-22.
60. Ruf B, Schurmann D, Horbach I, Fehrenbach FJ, Pohle HD. The incidence of legionella pneumonia: a 1-year prospective study in a large community hospital. Lung 1989; 167:11-22.
61. Kothe H, Bauer T, Marre R, Suttorp N, Welte T, Dalhoff K; Competence Network for Community-Acquired Pneumonia Study Group. Outcome of community-acquired pneumonia: influence of age, residence status and antimicrobial treatment. Eur Respir J 2008; 32:139-46.
62. Levy M, Dromer F, Brion N, Leturdu F, Carbon C. Community-acquired pneumonia. importance of initial noninvasive bacteriologic and radiographic investigations. Chest 1988; 93:43-8.
63. Lehtomaki K, Leinonen M, Takala A, Hovi T, Herva E, Koskela M. Etiological diagnosis of pneumonia in military conscripts by combined use of bacterial culture and serological methods. Eur J Clin Microbiol Infect Dis 1988; 7:348-54.
64. Hohenthal U, Vainionpaa R, Meurman O, et al. Aetiological diagnosis of community acquired pneumonia: utility of rapid microbiological methods with respect to disease severity. Scand J Infect Dis 2008; 40:131-8.
65. Leesik H, Ani U, Juhani A, Altraja A. Microbial pathogens of adult community-acquired pneumonia in Southern Estonia. Medicina (Kaunas) 2006; 42:384-94.
66. White RJ, Blainey AD, Harrison KJ, Clarke SK. Causes of pneumonia presenting to a district general hospital. Thorax 1981; 36:566-70.
67. Bewick T, Sheppard C, Greenwood S, et al. Serotype prevalence in adults hospitalised with pneumococcal non-invasive community-acquired pneumonia. Thorax 2012; 67:540-5.
68. Ostergaard L, Andersen PL. Etiology of community-acquired pneumonia. Evaluation by transtracheal aspiration, blood culture, or serology. Chest 1993; 104:1400-7.
69. Marekovi I, Plecko V, Boras Z, et al. Evaluation of PCR as rapid microbiological method in diagnosis of pneumococcal pneumonia. Scand J Infect Dis 2008; 40:843-5.
70. Blasi F, Cosentini R, Legnani D, Denti F, Allegra L. Incidence of community-acquired pneumonia caused by Chlamydia pneumoniae in Italian patients. Eur J Clin Microbiol Infect Dis 1993; 12:696-9.
71. Logroscino CD, Penza O, Locicero S, et al. Community-acquired pneumonia in adults: a multicentric observational AIPO study. Monaldi Arch Chest Dis 1999; 54:11-7.
72. Cecil RL, Baldwin HS, Larsen NP. Clinical and bacteriological study of 2000 typed cases of lobar pneumonia. Arch Intern Med 1927; 40: 253-80.
73. Cole RI. Acute pulmonary infections, Delamar Lectures. Baltimore: Williams and Wilkins Co, 1927.
74. Heffron R. Pneumonia with special reference to pneumococcus lobar pneumonia. New York: The Commonwealth Fund, 1939.
75. Francis T Jr. Influenza. In: Rivers TM, Horsfall FL, Jr. Viral and Rickettsial Diseases of Man. Third ed. Philadelphia: J. B. Lippincott:633-72.
76. Morens DM, Taubenberger JK, Fauci AS. Predominant role of bacterial pneumonia as a cause of death in pandemic influenza: implications for pandemic influenza preparedness. J Infect Dis 2008; 198:962-70.
77. Hilleman MR, Werner JH. Recovery of new agent from patients with acute respiratory illness. Proc Soc Exp Biol Med 1954; 85:183-8.
78. Reimann HA. An acute infection of the respiratory tract with atypical pneumonia. A disease entity probably caused by a filterable virus. JAMA 1938; 111: 2377-84.
79. Reimann HA. Pneumococcal and "virus" pneumonia. Bull N Y Acad Med 1941; 17:187-94.
80. Chanock RM, Mufson MA, Bloom HH, James WD, Fox HH, Kingston JR. Eaton agent pneumonia. JAMA 1961; 175:213-20.
81. Eaton MD, Van Herick W. Serological and epidemiological studies on primary atypical pneumonia and related acute upper respiratory disease. Am J Hyg 1947; 45:82-95.
82. Chanock RM, Rifkind D, Kravetz HM, Kinght V, Johnson KM. Respiratory disease in volunteers infected with Eaton agent: a preliminary report. Proc Natl Acad Sci USA 1961; 47:887-90.
83. Mufson MA, Chang V, Gill V, Wood SC, Romansky MJ, Chanock RM. The role of viruses, mycoplasmas and bacteria in acute pneumonia in civilian adults. Am J Epidemiol 1967; 86:526-44.
84. Foy HM, Kenny GE, McMahan R, Mansy AM, Grayston JT. Mycoplasma pneumoniae pneumonia in an urban area. Five years of surveillance. JAMA 1970; 214:1666-72.
85. Clinical patterns of undifferentiated and other acute respiratory diseases in Army recruits. Medicine (Baltimore) 1947; 26:441-64.
86. Wood WBJ. Pneumonia. Pneumococcal pneumonia. In: Beeson PB, McDermott W. Cecil-Loeb Textbook of Medicine. Twelfth ed. Philadelphia and London: W. B. Saunders Co., 1967:145-59.
87. Veillon A, Zuber A. Recherches sur quelques microbes strictement anaerobies et leur role en pathologie. Arch MedExper d'Anat Path 1898; 10:517-45.
88. Smith DT. Fusospirochetal disease of the lungs, its bacteriology, pathology and experimental reproduction. Amer Rev Tuberc 1927; 16: 584-98.
89. Cohen J. The bacteriology of abscess of the lung and methods for its study. Arch Surg 1932; 24:171-88.
90. Bartlett JG, Gorbach SL, Finegold SM. The bacteriology of aspiration pneumonia. Am J Med 1974; 56:202-7.
91. Bartlett JG. Anaerobic bacterial infections of the lung and pleural space. Clin Infect Dis 1993; 16 Suppl 4:S248-55.
92. Hahn HH, Beaty HN. Transtracheal aspiration in the evaluation of patients with pneumonia. Ann Intern Med 1970; 72:183-7.
93. Hoeprich PD. Etiologic diagnosis of lower respiratory tract infections. Calif Med 1970; 112:1-8.
94. Bartlett JG, Rosenblatt JE, Finegold SM. Percutaneous transtracheal aspiration in the diagnosis of anaerobic pulmonary infection. Ann Intern Med 1973; 79:535-40.
95. Ries K, Levison ME, Kaye D. Transtracheal aspiration in pulmonary infection. Arch Intern Med 1974; 133:453-8.
96. Thorsteinsson SB, Musher DM, Fagan T. The diagnostic value of sputum culture in acute pneumonia. JAMA 1975; 233:894-5.
97. Bartlett JG. Anaerobic bacterial infections of the lung. Chest 1987; 91:901-9.
98. Bartlett JG. Diagnostic accuracy of transtracheal aspiration bacteriologic studies. Am Rev Respir Dis 1977; 115:777-82.
99. Fraser DW, Tsai TR, Orenstein W, et al. Legionnaires' disease: description of an epidemic of pneumonia. N Engl J Med 1977; 297:1189-97.
100. McDade JE, Shepard CC, Fraser DW, Tsai TR, Redus MA, Dowdle WR. Legionnaires' disease: isolation of a bacterium and demonstration of its role in other respiratory disease. N Engl J Med 1977; 297:1197-203.
101. Macrae AD, Lewis MJ. Legionnaires' disease in Nottingham. Lancet 1977; 2:1225-6.
102. Gorman GW, Yu VL, Brown A, et al. Isolation of Pittsburgh pneumonia agent from nebulizers used in respiratory therapy. Ann Intern Med 1980; 93:572-3.
103. Muder RR, Yu VL, Zuravleff JJ. Pneumonia due to the Pittsburgh pneumonia agent: new clinical perspective with a review of the literature. Medicine (Baltimore) 1983; 62:120-8.
104. Yu VL, Kroboth FJ, Shonnard J, Brown A, McDearman S, Magnussen M. Legionnaires' disease: new clinical perspective from a prospective pneumonia study. Am J Med 1982; 73:357-61.
105. Wadowsky RM, Yee RB, Mezmar L, Wing EJ, Dowling JN. Hot water systems as sources of Legionella pneumophila in hospital and nonhospital plumbing fixtures. Appl Environ Microbiol 1982; 43:1104-10.
106. Stout J, Yu VL, Vickers RM, et al. Ubiquitousness of Legionella pneumophila in the water supply of a hospital with endemic Legionnaires' disease. N Engl J Med 1982; 306:466-8.
107. Musher DM, Kubitschek KR, Crennan J, Baughn RE. Pneumonia and acute febrile tracheobronchitis due to Haemophilus influenzae. Ann Intern Med 1983; 99:444-50.
108. Grayston JT, Kuo CC, Wang SP, Altman J. A new Chlamydia psittaci strain, TWAR, isolated in acute respiratory tract infections. N Engl J Med 1986; 315:161-8.
109. Marrie TJ, Grayston JT, Wang SP, Kuo CC. Pneumonia associated with the TWAR strain of Chlamydia. Ann Intern Med 1987; 106:507-11.
110. Dowell SF, Anderson LJ, Gary HE Jr, et al. Respiratory syncytial virus is an important cause of community-acquired lower respiratory infection among hospitalized adults. J Infect Dis 1996; 174:456-62.
111. Couch RB, Englund JA, Whimbey E. Respiratory viral infections in immunocompetent and immunocompromised persons. Am J Med 1997; 102:2-9; discussion 25-6.
112. Stockton J, Stephenson I, Fleming D, Zambon M. Human metapneumovirus as a cause of community-acquired respiratory illness. Emerg Infect Dis 2002; 8:897-901.
113. Gutierrez F, Masia M, Rodriguez JC, et al. Evaluation of the immunochromatographic Binax NOW assay for detection of Streptococcus pneumoniae urinary antigen in a prospective study of community-acquired pneumonia in Spain. Clin Infect Dis 2003; 36:286-92.
114. Roson B, Fernandez-Sabe N, Carratala J, et al. Contribution of a urinary antigen assay (Binax NOW) to the early diagnosis of pneumococcal pneumonia. Clin Infect Dis 2004; 38:222-6.
115. Boulware DR, Daley CL, Merrifield C, Hopewell PC, Janoff EN. Rapid diagnosis of pneumococcal pneumonia among HIV-infected adults with urine antigen detection. J Infect 2007; 55:300-9.
116. Ishida T, Hashimoto T, Arita M, Tojo Y, Tachibana H, Jinnai M. A 3-year prospective study of a urinary antigen-detection test for Streptococcus pneumoniae in community-acquired pneumonia: utility and clinical impact on the reported etiology. J Infect Chemother 2004; 10:359-63.
117. Sinclair A, Xie X, Teltscher M, Dendukuri N. Systematic review and meta-analysis of a urine-based pneumococcal antigen test for diagnosis of community-acquired pneumonia caused by Streptococcus pneumoniae. J Clin Microbiol 2013; 51:2303-10.
118. Sheppard CL, Harrison TG, Smith MD, George RC. Development of a sensitive, multiplexed immunoassay using xMAP beads for detection of serotype-specific Streptococcus pneumoniae antigen in urine samples. J Med Microbiol 2011; 60:49-55.
119. Stralin K, Herrmann B, Abdeldaim G, Olcen P, Holmberg H, Molling P. Comparison of sputum and nasopharyngeal aspirate samples and of the PCR gene targets lytA and Spn9802 for quantitative PCR for rapid detection of pneumococcal pneumonia. J Clin Microbiol 2014; 52:83-9.
120. Musher DM, Mediwala R, Phan HM, Chen G, Baughn RE. Nonspecificity of assaying for IgG antibody to pneumolysin in circulating immune complexes as a means to diagnose pneumococcal pneumonia. Clin Infect Dis 2001; 32:534-8.
121. File TM Jr, Low DE, Eckburg PB, et al. Integrated analysis of FOCUS 1 and FOCUS 2: randomized, doubled-blinded, multicenter phase 3 trials of the efficacy and safety of ceftaroline fosamil versus ceftriaxone in patients with community-acquired pneumonia. Clin Infect Dis 2010; 51:1395-405.
122. Sherwin RL, Gray S, Alexander R, et al. Distribution of 13-valent pneumococcal conjugate vaccine Streptococcus pneumoniae serotypes in US adults aged 50 years with community-acquired pneumonia. J Infect Dis 2013; 208:1813-20.
123. Lim WS, Macfarlane JT, Boswell TC, et al. Study of community acquired pneumonia aetiology (SCAPA) in adults admitted to hospital: implications for management guidelines. Thorax 2001; 56:296-301.
124. Macfarlane JT, Colville A, Guion A, Macfarlane RM, Rose DH. Prospective study of aetiology and outcome of adult lower-respiratory-tract infections in the community. Lancet 1993; 341:511-4.
125. Johansson N, Kalin M, Hedlund J. Clinical impact of combined viral and bacterial infection in patients with community-acquired pneumonia. Scand J Infect Dis 2011; 43:609-15.
126. Snijders D, Daniels JM, de Graaff CS, van der Werf TS, Boersma WG. Efficacy of corticosteroids in community-acquired pneumonia: a randomized double-blinded clinical trial. Am J Respir Crit Care Med 2010; 181:975-82.
127. Moberley S, Holden J, Tatham DP, Andrews RM. Vaccines for preventing pneumococcal infection in adults. Cochrane Database Syst Rev 2013; 1:CD000422.
128. Centers for Disease Control and Prevention. Current cigarette smoking among adults-United States, 2011. MMWR Morb Mortal Wkly Rep 2012: 889-94.
129. Rozenbaum MH, Pechlivanoglou P, van der Werf TS, Lo-Ten-Foe JR, Postma MJ, Hak E. The role of Streptococcus pneumoniae in community-acquired pneumonia among adults in Europe: a meta-analysis. Eur J Clin Microbiol Infect Dis 2013; 32:305-16.
130. Huijts SM, Pride MW, Vos JM, et al. Diagnostic accuracy of a serotype-specific antigen test in community-acquired pneumonia. Eur Respir J 2013; 42:1283-90.
131. Karhu J, Ala-Kokko TI, Vuorinen T, Ohtonen P, Syrjala H. Lower respiratory tract virus findings in mechanically ventilated patients with severe community-acquired pneumonia. Clin Infect Dis 2014; 59:62-70.
132. Musher DM, Thorner AR. Community-acquired pneumonia. N Engl J Med 2014; 371:1619-28.
133. Barrera CM, Mykietiuk A, Metev H, et al; SOLITAIRE-ORAL Pneumonia Team. Efficacy and safety of oral solithromycin versus oral moxifloxacin for treatment of community-acquired bacterial pneumonia: a global, double-blind, multicentre, randomised, active-controlled, non-inferiority trial (SOLITAIRE-ORAL). Lancet Infect Dis 2016; 16:421-30.
134. File TM Jr, Rewerska B, Vucinic-Mihailovic V, et al. SOLITAIRE-IV: a randomized, double-blind, multicenter study comparing the efficacy and safety of intravenous-to-oral solithromycin to intravenous-to-oral moxifloxacin for treatment of community-acquired bacterial pneumonia. Clin Infect Dis 2016; 63:1007-16.
135. Leeming JP, Cartwright K, Morris R, Martin SA, Smith MD; South-West Pneumococcus Study Group. Diagnosis of invasive pneumococcal infection by serotype-specific urinary antigen detection. J Clin Microbiol 2005; 43:4972-6.
136. Bonten MJ, Huijts SM, Bolkenbaas M, et al. Polysaccharide conjugate vaccine against pneumococcal pneumonia in adults. N Engl J Med 2015; 372:1114-25.
137. Kobayashi M, Bennett NM, Gierke R, et al. Intervals between PCV13 and PPSV23 vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 2015; 64:944-7.
138. Albrich WC, Madhi SA, Adrian PV, et al. Use of a rapid test of pneumococcal colonization density to diagnose pneumococcal pneumonia. Clin Infect Dis 2012; 54:601-9.
139. Messaoudi M, Milenkov M, Albrich WC, et al. The relevance of a novel quantitative assay to detect up to 40 major Streptococcus pneumoniae serotypes directly in clinical nasopharyngeal and blood specimens. PLoS One 2016; 11:e0151428.
140. Gadsby NJ, Russell CD, McHugh MP, et al. Comprehensive molecular testing for respiratory pathogens in community-acquired pneumonia. Clin Infect Dis 2016; 62:817-23.